JW Therapeutics is an independent and innovative biotechnology company, focused on research, production, and commercialization of cell immunotherapy products. With a vision to be a leader in cell immunotherapy, the company was founded in 2016 and has successfully built an internationally renowned comprehensive platform for cell immunotherapy product development. Their product pipeline covers hematologic tumors, solid tumors, and autoimmune diseases.

JW Therapeutics is dedicated to bringing hope to patients in China and around the world with groundbreaking, high-quality cell immunotherapy products, while leading the healthy and regulated development of the cell immunotherapy industry in China. With their commitment to innovation, JW Therapeutics aims to make a significant impact on the field of cellular immunotherapy, providing patients with the possibility of a cure